media release moderna lonza mrna-1273/media/files/japan/news/200501... · 2020. 8. 3. ·...

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

MEDIA RELEASE

Moderna Lonza

mRNA-1273

10

2020 6

mRNA-1273 2020 7 Lonza

Lonza

Moderna Stéphane Bancel

Lonza

Moderna mRNA-1273

10

Lonza

10 mRNA-

1273

Lonza CEO Albert M. Baehny

Moderna

Moderna mRNA-1273 Moderna

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

2020 5 1 ( ) –

RNA (mRNA)

Moderna, Inc., (Nasdaq: MRNA) Lonza Ltd.

(SIX:LONN) (SARS-CoV-2) Moderna mRNA

(mRNA-1273) Moderna 10

mRNA-1273 Lonza

2020 6 2020 7

Lonza U.S mRNA-1273 Lonza

50μg 10 mRNA-1273

Lonza Moderna

mRNA-1273

2020 4 16

Biomedical Advanced Research and Development Authority (BARDA) Moderna

Lonza U.S BARDA

mRNA-1273 50

Lonza

Moderna

Moderna 2020 4 27 1

(FDA) mRNA-1273 2 IND

(Investigational New Drug) ( ) Moderna

2 FDA

2020 2 mRNA-1273 28

2

50μg 250μg

18 55 (n=300) 55 (n=300) 2 600

2 12

mRNA-1273

mRNA-1273 Spike (S) SARS-CoV-2 mRNA

NIH (NIAID)

(VRC) Moderna Coalition for Epidemic

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

Preparedness Innovations 2020 2 7

42 2 24 NIH mRNA-

1273 NIAID 1 1 63

3 16 SARS-CoV-2

NIAID 1

mRNA-1273 1

(IND) 2020 3 16 1

3 (25μg 100μg 250μg) 18 55 45

6 : (56 70 ) 3

(71 ) 3 18 55

Moderna

Moderna

Moderna

1,400

Moderna

1

mRNA

mRNA 1

mRNA

Moderna

Moderna 9

:

• (RSV) (Merck mRNA-

1777 mRNA-1172 V172)

• RSV (mRNA-1345)

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

• (hMPV) 3 (PIV3)

(mRNA-1653)

• (SARS-CoV-2) ( mRNA-1273)

• H7N9 (mRNA-1851)

• (CMV) (mRNA-1647)

• (mRNA-1893 BARDA)

• (EBV) (mRNA-1189)

Moderna 7 (H10N8 H7N9 RSV

hMPV/PIV3 CMV ) 1

Moderna CMV 2

1 Moderna (mRNA-1893) 2019 8 FDA Fast

Track

Lonza

Lonza

Lonza

1897 Lonza 35 120

15,500 Lonza

2019 59

CORE EBITDA 16 www.Lonza.com

Twitter@LonzaGroup Facebook@LonzaGroupAG

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

Moderna

Moderna RNA (mRNA)

mRNA

mRNA

Moderna

Moderna

AstraZeneca PLC Merk & Co.,Inc.

Defense Advanced Research Projects Agency (DARPA)

(HHS) Office of the Assistant Secretary for Preparedness and

Response (ASPR) Biomedical Advanced Research and Development Authority

(BARDA) Moderna 5

Science 10

www.modenatx.com

- Lonza

Media: Dr. Sanna Fowler Head of External Communications +41 79 539 0615 sanna.fowler@lonza.com Victoria Morgan Head of Corporate Communications +41 79 599 6260 victoria.morgan@lonza.com Investor Relations: Dirk Oehlers Investor Relations Director +41 79 421 1609 dirk.oehlers@lonza.com

Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ media@lonza.com

- Moderna

Media: Colleen Hussey Senior Manager, Corporate Communications 203-470-5620 Colleen.Hussey@modernatx.com Dan Budwick 1AB 973-271-6085 Dan@1abmedia.com Investors: Lavina Talukdar Head of Investor Relations 617-209-5834 TLavina.Talukdar@modernatx.com

Lonza

SGX-ST Lonza

SGXST SGXST 217

751

Lonza

Lonza

Lonza

Lonza Group Ltd 2020 5 1

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus